Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4906

1.

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.

Doi T, Matsubara N, Kawai A, Naka N, Takahashi S, Uemura H, Yamamoto N.

Invest New Drugs. 2019 Dec 10. doi: 10.1007/s10637-019-00859-4. [Epub ahead of print]

PMID:
31820255
2.

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.

Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T.

Lung Cancer. 2019 Nov 28;139:195-199. doi: 10.1016/j.lungcan.2019.11.025. [Epub ahead of print]

PMID:
31812890
3.

Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.

Oneyama M, Sakamoto N, Oue N, Kimura Y, Hiroshima Y, Hashimoto I, Hara K, Maezawa Y, Kano K, Aoyama T, Fujikawa H, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Yukawa N, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Miyagi Y, Yasui W, Oshima T.

Anticancer Res. 2019 Dec;39(12):6567-6573. doi: 10.21873/anticanres.13872.

PMID:
31810922
4.

Glycogen Synthase Kinase 3β as a Potential Therapeutic Target in Synovial Sarcoma and Fibrosarcoma.

Abe K, Yamamoto N, Domoto T, Bolidong D, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Inatani H, Aoki Y, Higuchi T, Taniguchi Y, Yonezawa H, Araki Y, Aiba H, Minamoto T, Tsuchiya H.

Cancer Sci. 2019 Dec 6. doi: 10.1111/cas.14271. [Epub ahead of print]

5.

Joint-preservation surgery for pediatric osteosarcoma of the knee joint.

Takeuchi A, Yamamoto N, Hayashi K, Matsubara H, Miwa S, Igarashi K, Tsuchiya H.

Cancer Metastasis Rev. 2019 Dec 5. doi: 10.1007/s10555-019-09835-z. [Epub ahead of print] Review.

PMID:
31807972
6.

First-in-human phase I study of E7090, a novel selective FGFR inhibitor, in patients with advanced solid tumors.

Koyama T, Shimizu T, Iwasa S, Fujiwara Y, Kondo S, Kitano S, Yonemori K, Shimomura A, Iizumi S, Sasaki T, Furuse J, Yamamoto N.

Cancer Sci. 2019 Dec 2. doi: 10.1111/cas.14265. [Epub ahead of print]

7.

Severe fever with thrombocytopenia syndrome complicated with subdural hematoma: A rare case and literature review.

Endo T, Yamamoto N, Inoue S, Yoshikane T, Fujisawa N, Imada T, Hattori S.

J Gen Fam Med. 2019 Sep 9;20(6):251-254. doi: 10.1002/jgf2.273. eCollection 2019 Nov.

8.

The plant-type phosphoenolpyruvate carboxylase Gmppc2 is developmentally induced in immature soy seeds at the late maturation stage: a potential protein biomarker for seed chemical composition.

Yamamoto N, Sugimoto T, Takano T, Sasou A, Morita S, Yano K, Masumura T.

Biosci Biotechnol Biochem. 2019 Nov 27:1-11. doi: 10.1080/09168451.2019.1696179. [Epub ahead of print]

PMID:
31771419
9.

Rho Guanine Nucleotide Exchange Factors Regulate Horizontal Axon Branching of Cortical Upper Layer Neurons.

Sasaki K, Arimoto K, Kankawa K, Terada C, Yamamori T, Watakabe A, Yamamoto N.

Cereb Cortex. 2019 Nov 20. pii: bhz256. doi: 10.1093/cercor/bhz256. [Epub ahead of print]

PMID:
31768529
10.

Monitoring the health-related Sustainable Development Goals: lessons learned and recommendations for improved measurement.

Asma S, Lozano R, Chatterji S, Swaminathan S, de Fátima Marinho M, Yamamoto N, Varavikova E, Misganaw A, Ryan M, Dandona L, Minghui R, Murray CJL.

Lancet. 2019 Nov 22. pii: S0140-6736(19)32523-1. doi: 10.1016/S0140-6736(19)32523-1. [Epub ahead of print] Review. No abstract available.

PMID:
31767190
11.

Effects of bilateral cochlear implants in children: Timing of second surgery and the significance of wearing bilateral cochlear implants in Japan.

Mori N, Yamaguchi S, Ishida A, Kondo K, Okano T, Ito J, Omori K, Yamamoto N.

Auris Nasus Larynx. 2019 Nov 22. pii: S0385-8146(19)30924-1. doi: 10.1016/j.anl.2019.11.001. [Epub ahead of print]

PMID:
31767153
12.

Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.

Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K.

J Am Heart Assoc. 2019 Dec 3;8(23):e014096. doi: 10.1161/JAHA.119.014096. Epub 2019 Nov 26.

13.

Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.

Yamaguchi I, Kanematsu Y, Shimada K, Korai M, Miyamoto T, Shikata E, Yamaguchi T, Yamamoto N, Yamamoto Y, Kitazato KT, Okayama Y, Takagi Y.

Cerebrovasc Dis Extra. 2019 Nov 22;9(3):129-138. doi: 10.1159/000504163. [Epub ahead of print]

14.

Peripheral-Track and Central-Track Hill-Sachs Lesions: A New Concept of Assessing an On-Track Lesion.

Yamamoto N, Shinagawa K, Hatta T, Itoi E.

Am J Sports Med. 2019 Nov 22:363546519886319. doi: 10.1177/0363546519886319. [Epub ahead of print]

PMID:
31756135
15.

Evolution of Aspergillus oryzae before and after domestication inferred by large-scale comparative genomic analysis.

Watarai N, Yamamoto N, Sawada K, Yamada T.

DNA Res. 2019 Nov 22. pii: dsz024. doi: 10.1093/dnares/dsz024. [Epub ahead of print]

PMID:
31755931
16.

High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.

Maezawa Y, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Kano K, Aoyama T, Hiroshima Y, Yamada T, Yamamoto N, Ogata T, Ito H, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T.

J Cancer Res Clin Oncol. 2019 Nov 21. doi: 10.1007/s00432-019-03087-8. [Epub ahead of print]

PMID:
31754833
17.

Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.

Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Yoshimoto N, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Hirata K, Koh Y, Kawaguchi T.

Lung Cancer. 2019 Nov 2;139:80-88. doi: 10.1016/j.lungcan.2019.10.029. [Epub ahead of print]

PMID:
31751804
18.

Improved survival among patients enrolled in oncology phase 1 trials in recent decades.

Ebata T, Shimizu T, Koyama T, Shimomura A, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Yamamoto N.

Cancer Chemother Pharmacol. 2019 Nov 19. doi: 10.1007/s00280-019-03992-2. [Epub ahead of print]

PMID:
31745590
19.

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.

Shibaki R, Murakami S, Matsumoto Y, Yoshida T, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Kusumoto M, Yamamoto N, Ohe Y.

Cancer Immunol Immunother. 2019 Nov 19. doi: 10.1007/s00262-019-02431-8. [Epub ahead of print]

PMID:
31745589
20.

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.

Akamatsu H, Murakami E, Oyanagi J, Shibaki R, Kaki T, Takase E, Tanaka M, Harutani Y, Yamagata N, Okuda Y, Furuta K, Sugimoto T, Teraoka S, Hayata A, Tokudome N, Ozawa Y, Mori K, Koh Y, Yamamoto N.

Oncologist. 2019 Nov 19. pii: theoncologist.2019-0299. doi: 10.1634/theoncologist.2019-0299. [Epub ahead of print]

PMID:
31744931
21.

Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae.

Abe R, Hagiya H, Akeda Y, Yamamoto N, Ishii Y, Tomono K.

BMC Res Notes. 2019 Nov 9;12(1):740. doi: 10.1186/s13104-019-4779-x.

22.

Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37.

Tatsuta M, Kan-O K, Ishii Y, Yamamoto N, Ogawa T, Fukuyama S, Ogawa A, Fujita A, Nakanishi Y, Matsumoto K.

Respir Res. 2019 Nov 9;20(1):251. doi: 10.1186/s12931-019-1226-4.

23.

The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.

Higuchi T, Sugisawa N, Yamamoto J, Oshiro H, Han Q, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Tan Y, Kuchipudi S, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Chemother Pharmacol. 2019 Nov 8. doi: 10.1007/s00280-019-03986-0. [Epub ahead of print]

PMID:
31705268
24.

Anti-tumor Effects of Cyclolinopeptide on Giant-cell Tumor of the Bone.

Taniguchi Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Higuchi T, Abe K, Yonezawa H, Araki Y, Morinaga S, Kamei J, Nugroho AE, Kaneda T, Morita H, Tsuchiya H.

Anticancer Res. 2019 Nov;39(11):6145-6153. doi: 10.21873/anticanres.13822.

PMID:
31704842
25.

A retrospective study of antibacterial iodine-coated implants for postoperative infection.

Shirai T, Tsuchiya H, Terauchi R, Tsuchida S, Mizoshiri N, Mori Y, Takeuchi A, Hayashi K, Yamamoto N, Ikoma K, Kubo T.

Medicine (Baltimore). 2019 Nov;98(45):e17932. doi: 10.1097/MD.0000000000017932.

26.

Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.

Watanabe T, Minezawa T, Hasegawa M, Goto Y, Okamura T, Sakakibara Y, Niwa Y, Kato A, Hayashi M, Isogai S, Kondo M, Yamamoto N, Hashimoto N, Imaizumi K.

BMC Pulm Med. 2019 Nov 1;19(1):194. doi: 10.1186/s12890-019-0969-5.

27.

In Which Arm Position Is a Hill-Sachs Lesion Created? Response.

Kawakami J, Yamamoto N, Hatta T, Shinagawa K, Itoi E.

Am J Sports Med. 2019 Nov;47(13):NP74-NP75. doi: 10.1177/0363546519878140. No abstract available.

PMID:
31675268
28.

Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.

Hiroshima Y, Kasajima R, Kimura Y, Komura D, Ishikawa S, Ichikawa Y, Bouvet M, Yamamoto N, Oshima T, Morinaga S, Singh SR, Hoffman RM, Endo I, Miyagi Y.

Cancer Lett. 2020 Jan 28;469:217-227. doi: 10.1016/j.canlet.2019.10.031. Epub 2019 Oct 24.

PMID:
31669204
29.

Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.

Iwama E, Goto Y, Murakami H, Tsumura S, Sakashita H, Mori Y, Nakagaki N, Fujita Y, Seike M, Bessho A, Ono M, Nishitsuji M, Akamatsu H, Morinaga R, Akagi T, Shimose T, Tokunaga S, Yamamoto N, Nakanishi Y, Sugio K, Okamoto I.

Oncologist. 2019 Oct 30. pii: theoncologist.2019-0728. doi: 10.1634/theoncologist.2019-0728. [Epub ahead of print]

PMID:
31666370
30.

Broadband dielectric spectroscopy from sub GHz to THz of hydrated lipid bilayer of DMPC.

Kadomura Y, Yamamoto N, Tominaga K.

Eur Phys J E Soft Matter. 2019 Oct 30;42(10):139. doi: 10.1140/epje/i2019-11901-1.

PMID:
31664606
31.

Treatment of chordoma-where is it going?

Yamamoto N, Tsuchiya H.

J Spine Surg. 2019 Sep;5(3):387-389. doi: 10.21037/jss.2019.09.01. No abstract available.

32.

Central Injection of Leptin Increases Sympathetic Nerve Outflows to the Stomach and Spleen in Anesthetized Rats.

Tanida M, Iwasaki Y, Yamamoto N.

In Vivo. 2019 Nov-Dec;33(6):1827-1832. doi: 10.21873/invivo.11675.

PMID:
31662509
33.

Molecular Mobility Suppression of Ibuprofen-Rich Amorphous Nanodroplets by HPMC Revealed by NMR Relaxometry and Its Significance with Respect to Crystallization Inhibition.

Ueda K, Yamamoto N, Higashi K, Moribe K.

Mol Pharm. 2019 Nov 11. doi: 10.1021/acs.molpharmaceut.9b00840. [Epub ahead of print]

PMID:
31661287
34.

Drastically progressive lung cavity lesion caused by Actinomyces odontolyticus in a patient undergoing chemoradiotherapy: A case report and literature review.

Matsumoto T, Kusakabe Y, Enomoto M, Yamamoto N, Aihara K, Yamaoka S, Mishima M.

Respir Med Case Rep. 2019 Oct 14;28:100950. doi: 10.1016/j.rmcr.2019.100950. eCollection 2019.

35.

Pretreatment diagnosis factors associated with overtreatment with surgery in patients with differentiated-type early gastric cancer.

Horiuchi Y, Fujisaki J, Yamamoto N, Ida S, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Sci Rep. 2019 Oct 25;9(1):15356. doi: 10.1038/s41598-019-51952-w.

36.

Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.

Harada Y, Takahashi H, Trusheim H, Roth B, Mizuta K, Hirata-Saito A, Ogane T, Odagiri T, Tashiro M, Yamamoto N.

Influenza Other Respir Viruses. 2019 Oct 25. doi: 10.1111/irv.12694. [Epub ahead of print]

37.

Public reactions to direct-to-consumer genetic health tests: A comparison across the US, UK, Japan and Australia.

Charbonneau J, Nicol D, Chalmers D, Kato K, Yamamoto N, Walshe J, Critchley C.

Eur J Hum Genet. 2019 Oct 23. doi: 10.1038/s41431-019-0529-8. [Epub ahead of print]

PMID:
31645768
38.

External iliac artery thrombosis following open reduction of acetabular fracture: a case report and literature review.

Yamamoto N, Noda T, Saito T, Uehara T, Shimamura Y, Ozaki T.

Arch Orthop Trauma Surg. 2019 Oct 23. doi: 10.1007/s00402-019-03288-3. [Epub ahead of print]

PMID:
31642955
39.

Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.

Ito A, Kitano S, Tajima K, Kim Y, Tanaka T, Inamoto Y, Kim SW, Yamamoto N, Fukuda T, Okamoto S.

Int J Hematol. 2019 Oct 22. doi: 10.1007/s12185-019-02756-1. [Epub ahead of print]

PMID:
31641956
40.

Patient-derived orthotopic xenograft models of sarcoma.

Igarashi K, Kawaguchi K, Murakami T, Miyake K, Kiyuna T, Miyake M, Hiroshima Y, Higuchi T, Oshiro H, Nelson SD, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Lett. 2020 Jan 28;469:332-339. doi: 10.1016/j.canlet.2019.10.028. Epub 2019 Oct 19.

PMID:
31639427
41.

Correction: Taxonomic diversity of fungi deposited from the atmosphere.

Woo C, An C, Xu S, Yi SM, Yamamoto N.

ISME J. 2019 Oct 21. doi: 10.1038/s41396-019-0534-5. [Epub ahead of print]

PMID:
31636365
42.

Genomic characterisation of a novel plasmid carrying blaIMP-6 of carbapenem-resistant Klebsiella pneumoniae isolated in Osaka, Japan.

Abe R, Akeda Y, Sakamoto N, Kumwenda G, Sugawara Y, Yamamoto N, Kawahara R, Tomono K, Fujino Y, Hamada S.

J Glob Antimicrob Resist. 2019 Oct 15. pii: S2213-7165(19)30257-7. doi: 10.1016/j.jgar.2019.10.003. [Epub ahead of print]

43.

Living myofibroblast-silicon composites for probing electrical coupling in cardiac systems.

Rotenberg MY, Yamamoto N, Schaumann EN, Matino L, Santoro F, Tian B.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22531-22539. doi: 10.1073/pnas.1913651116. Epub 2019 Oct 17.

PMID:
31624124
44.

Effect of subcritical glenoid bone loss on activities of daily living in patients with anterior shoulder instability.

Yamamoto N, Kawakami J, Hatta T, Itoi E.

Orthop Traumatol Surg Res. 2019 Dec;105(8):1467-1470. doi: 10.1016/j.otsr.2019.08.015. Epub 2019 Oct 14.

PMID:
31624030
45.

Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.

Kenmotsu H, Yoh K, Mori K, Ono A, Baba T, Fujiwara Y, Yamaguchi O, Ko R, Okamoto H, Yamamoto N, Ninomiya T, Ogura T, Kato T.

Cancer Sci. 2019 Dec;110(12):3738-3745. doi: 10.1111/cas.14217. Epub 2019 Nov 6.

46.

Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy.

Tajima S, Yamamoto N, Masuda S.

Biochem Pharmacol. 2019 Dec;170:113664. doi: 10.1016/j.bcp.2019.113664. Epub 2019 Oct 10. Review.

PMID:
31606409
47.

Calcaneal insufficiency fractures following total knee arthroplasty: Classification and clinical findings.

Yamamoto N, Tsukada S, Kawai J, Ueda D, Noda T, Ozaki T.

Injury. 2019 Dec;50(12):2339-2345. doi: 10.1016/j.injury.2019.10.017. Epub 2019 Oct 7.

PMID:
31606135
48.

Identifying characteristics of indicators of sedentary behavior using objective measurements.

Yamamoto K, Matsuda F, Matsukawa T, Yamamoto N, Ishii K, Kurihara T, Yamada S, Matsuki T, Kamijima M, Ebara T.

J Occup Health. 2019 Oct 10. doi: 10.1002/1348-9585.12089. [Epub ahead of print]

49.

Mechanism of atopic cataract caused by eosinophil granule major basic protein.

Yamamoto N, Hiramatsu N, Isogai S, Kondo M, Imaizumi K, Horiguchi M.

Med Mol Morphol. 2019 Oct 8. doi: 10.1007/s00795-019-00234-5. [Epub ahead of print]

PMID:
31595373
50.

Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y.

Sci Rep. 2019 Oct 8;9(1):14730. doi: 10.1038/s41598-019-50828-3.

Supplemental Content

Loading ...
Support Center